Logipharm Limited, headquartered in Great Britain, is a leading player in the pharmaceutical logistics industry, specialising in supply chain solutions for healthcare providers. Founded in 2005, the company has established a strong presence across Europe, focusing on the efficient distribution of medical products and pharmaceuticals. With a commitment to innovation, Logipharm offers unique services such as temperature-controlled logistics and real-time tracking systems, ensuring the integrity of sensitive products throughout the supply chain. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and recognition for its commitment to quality and compliance. Logipharm Limited stands out in the market for its tailored solutions and customer-centric approach, solidifying its position as a trusted partner in the healthcare logistics sector.
How does Logipharm Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Logipharm Limited's score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Logipharm Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Logipharm Limited may be in the early stages of developing a comprehensive climate strategy or may not yet have established formal targets for carbon reduction. As the industry increasingly prioritises sustainability, it will be essential for Logipharm Limited to consider implementing measurable climate initiatives to align with best practices and stakeholder expectations.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Logipharm Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
